![Study Results & Research Projects Study Results & Research Projects](https://webarchive.library.unt.edu/eot2008/20090131040808im_/http://ntp-server.niehs.nih.gov/images/template/subMastHead_studyResults.gif)
NTP Study Reports
NTP Study Reports
Home » Study Results & Research Projects » NTP Study Reports » All Long-Term Reports » Abstract for TR-490 - Glutaraldehyde
Chemical Formula: C5H8O2 | - | 3D Structure* |
---|---|---|
*To view structure, download free Chemscape Chime Plug-in |
Glutaraldehyde is used in large volume in a variety of industries as a disinfectant, preservative, fixative and cross-linking agent, and as a chemical intermediate in the synthesis of pharmaceuticals and pesticides. Glutaraldehyde was nominated by the National Cancer Institute, the Occupational Safety and Health Administration, and the National Institute of Environmental Health Sciences for carcinogenicity studies because of potential occupational exposure. Male and female F344/N rats and B6C3F1 mice were exposed to glutaraldehyde (25% aqueous solution) (approximately 93% pure) by inhalation for 2 years. In vitro genetic toxicology studies were conducted in Salmonella typhimurium, L5178Y mouse lymphoma cells, and cultured Chinese hamster ovary cells; in vivo studies were conducted to measure sex-linked recessive lethal mutations in Drosophila melanogaster, chromosomal aberrations and micronucleated erythrocytes in mouse bone marrow, and micronucleated erythrocytes in mouse peripheral blood. The results of 13-week inhalation studies with glutaraldehyde were reported previously (NTP, 1993 -- TOX-25 ).
Groups of 50 male and 50 female F344/N rats were exposed to 0, 250, 500, or 750 ppb glutaraldehyde vapor by inhalation, 6 hours per day, 5 days per week, for 104 weeks. Survival of 500 and 750 ppb female rats was less than that of the chamber controls. Mean body weights of all exposed groups of male rats and 500 and 750 ppb female rats were generally less than those of the chamber controls. Some female rats exposed to 750 ppb were thin to emaciated at the time they were killed moribund. Increased incidences of nonneoplastic nasal lesions occurred primarily within the anterior section of the nose in 500 and 750 ppb rats and to a lesser extent in 250 ppb rats. The more significant lesions included hyperplasia and inflammation of the squamous and respiratory epithelia and squamous metaplasia of the respiratory epithelium.
Groups of 50 male and 50 female B6C3F1 mice were exposed to 0, 62.5, 125, or 250 ppb glutaraldehyde vapor by inhalation, 6 hours per day, 5 days per week, for 104 weeks. Survival of exposed mice was similar to that of the chamber controls. Mean body weights of female mice exposed to 250 ppb were generally less than those of the chamber controls throughout the study. Incidences of squamous meta-plasia of the respiratory epithelium were increased in 250 ppb males and females and 125 ppb females. Incidences of hyaline degeneration of the respiratory epithelium were increased in all exposed groups of females. The incidence of inflammation of the nose was marginally increased in 250 ppb females.
In genetic toxicity studies, glutaraldehyde was muta-genic with and without S9 metabolic activation in S. typhimurium strains TA100, TA102, and TA104. Glutaraldehyde was mutagenic in mouse L5178Y lymphoma cells in the absence of S9 and induced sister chromatid exchanges in cultured Chinese hamster ovary cells with and without S9. No increase in chromosomal aberrations was induced by glutaraldehyde in cultured Chinese hamster ovary cells with or without S9 at one laboratory; at another laboratory, chromosomal aberrations were induced in the absence of S9 only. Glutaraldehyde did not induce sex-linkedrecessive lethal mutations in germ cells of male D. melanogaster treated as adults by feeding or injection or treated as larvae by feeding. In vivo, glutaraldehyde induced a significant increase in chromosomal aberrations in mouse bone marrow cells 36 hours after a single intraperitoneal injection. In a subset of the 36-hour chromosomal aberrations test, there was a small increase in the number of micronucleated bone marrow polychromatic eryth-rocytes, which was judged to be equivocal. Addi-tional short-term (3-day) and subchronic (13-week) micronucleus tests in mice, using the intraperitoneal or inhalation routes, respectively, yielded negative results.
Under the conditions of these 2-year inhalation studies, there was no evidence of carcinogenic activity of glutaraldehyde in male or female F344/N rats exposed to 250, 500, or 750 ppb. There was no evidence of carcinogenic activity in male or female B6C3F1 mice exposed to 62.5, 125, or 250 ppb.
Incidences of nonneoplastic lesions of the nose were significantly increased in male and female rats and mice.
Synonyms: 1,3-Diformylpropane; glutaral; glutardialdehyde; glutaric dialdehyde; 1,5-pentanedial; 1,5-pentanedione; potentiated acid glutaraldehyde
Trade names: Cidex; Sonacide
Male
F344/N Rats |
Female F344/N Rats |
Male B6C3F1 Mice |
Female
B6C3F1 Mice | |
---|---|---|---|---|
Concentrations | Chamber control, 250, 500, or 750 ppb | Chamber control, 250, 500, or 750 ppb | Chamber control, 62.5, 125, or 250 ppb | Chamber control, 62.5, 125, or 250 ppb |
Body weights | Exposed groups generally less than chamber controls | 500 and 750 ppb groups less than chamber controls | Exposed groups similar to chamber controls | 250 ppb group less than chamber controls |
Survival rates | 12/50, 14/50, 9/50, 6/50 | 26/50, 31/50, 15/50, 14/50 | 31/50, 27/50, 40/50, 38/50 | 34/50, 37/50, 35/50, 32/50 |
Nonneoplastic effects | Nose: squamous epithelium hyperplasia (3/50, 11/50, 39/50, 48/50); squamous epithelium inflammation (6/50, 17/50, 41/50, 49/50); respiratory epithelium hyperplasia (6/50, 5/50, 17/50, 35/50); respiratory epithelium inflammation (17/50, 10/50, 25/50, 43/50); respiratory epithelium squamous metaplasia (1/50, 2/50, 11/50, 24/50); respiratory epithelium goblet cell hyperplasia (1/50, 0/50, 6/50, 6/50); olfactory epithelium hyaline degeneration (4/50, 8/50, 9/50, 14/50) | Nose: squamous epithelium hyperplasia (3/50, 15/50, 29/50, 45/49); squamous epithelium inflammation (6/50, 26/50, 42/50, 48/49); respiratory epithelium hyperplasia (1/50, 6/50, 15/50, 29/49); respiratory epithelium inflammation (5/50, 9/50, 26/50, 42/49); respiratory epithelium squamous metaplasia (1/50, 1/50, 11/50,16/49); respiratory epithelium goblet cell hyperplasia (1/50, 3/50, 5/50, 8/49); olfactory epithelium hyaline degeneration (4/50, 5/50, 12/50, 15/49) | Nose: respiratory epithelium squamous metaplasia (2/50, 5/50, 6/50, 9/50) | Nose: respiratory epithelium squamous metaplasia (7/50, 11/49, 16/50, 21/50); respiratory epithelium hyaline degeneration (16/50, 35/49, 32/50, 30/50); inflammation (6/50, 7/49, 13/50, 14/50) |
Neoplastic effects | None | None | None | None |
Level of evidence of carcinogenic activity | No evidence | No evidence | No evidence | No evidence |
Genetic toxicology | |
---|---|
Salmonella typhimurium gene mutations: | Positive in strains TA100, TA102, and TA104 with and without S9 |
Mouse lymphoma gene mutations: | Positive without S9 |
Sister chromatid exchanges
Cultured Chinese hamster ovary cells in vitro: | Positive with and without S9 |
Chromosomal aberrations
Cultured Chinese hamster ovary cells in vitro: |
Positive without S9 |
Mouse bone marrow in vivo: | Positive |
Sex-linked recessive lethal mutations
Drosophila melanogaster: | Negative |
Micronucleated erythrocytes
Mouse bone marrow in vivo: | Equivocal (single-injection protocol); negative (three-injection protocol) |
Mouse peripheral blood in vivo: | Negative |
Report Date: September 1999
Pathology Tables, Survival and Growth Curves from NTP 2-year Studies
Target Organs & Incidences from 2-year Studies
You may link to the full technical report in pdf format ( Note: A print ready copy of the document is presented in Portable Document Format (pdf) which requires the Acrobat Reader plug-in -- download a free copy of the reader.)
Web page last updated on October 11, 2007
The National Institute of Environmental Health Sciences is one of the National Institutes of Health within the U.S. Department of Health and Human Services. The National Toxicology Program is headquartered on the NIEHS campus in Research Triangle Park, NC.